Suchergebnisse - "Jerez, Yolanda"

PubPharm (52)

1

Correlation between breast cancer subtypes determined by immunohistochemistry and n-COUNTER PAM50 assay : a real-world study

enthalten in: Breast cancer research and treatment | 2024

von Lopez-Tarruella, S. | Del Monte-Millán, M. | Roche-Molina, M. | +19

2

Assessment of a Genomic Assay in Patients With ERBB2-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without Pertuzumab

enthalten in: JAMA oncology | 2023

von Bueno-Muiño, C. | Echavarría, I. | López-Tarruella, S. | +24

3

Long-lasting biofouling formation on transparent fouling-release coatings for the construction of efficient closed photobioreactors

enthalten in: Biofouling | 2023

von Soriano-Jerez, Y. | García-Abad, L. | Cerón-García, M. | +4

4

Microalgal biofouling formation on tubular cellulose-ester membranes during dewatering by forward osmosis

enthalten in: Biofouling | 2023

von Karamad Yazdanabad, S. | Soriano Jerez, Y. | Samimi, A. | +5

5

Adsorption Analysis of Exopolymeric Substances as a Tool for the Materials Selection of Photobioreactors Manufacture

enthalten in: International journal of molecular sciences | 2022

von García-Abad, L. | Soriano-Jerez, Y. | Cerón-García, M. | +4

6

Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von García-Sáenz, J. | Martínez-Jáñez, N. | Cubedo, R. | +14

7

How we treat HR-positive, HER2-negative early breast cancer

enthalten in: Future oncology (London, England) | 2022

von Lopez-Tarruella, S. | Echavarria, I. | Jerez, Y. | +3

8

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts

enthalten in: Scientific reports | 2021

von Martin, M. | Ramos-Medina, R. | Bernat, R. | +20

9

Activity Of Docetaxel, Carboplatin, And Doxorubicin In Patient-Derived Triple-Negative Breast Cancer Xenografts

enthalten in: ResearchSquare.com | 2021

von Martin, M. | Ramos-Medina, R. | Bernat, R. | +20

10

Neratinib for the treatment of early-stage, hormone receptor-positive, HER2-overexpressed breast cancer

enthalten in: Future oncology (London, England) | 2020

von Jerez, Y. | Herrero, B. | Arregui, M. | +3

1
2
3
4
5
6
Nächster »
[6]